EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GOSS: Gossamer Bio Inc

11 Feb 26 15:33
LAST:

2.310

CHANGE:
 0.04		OPEN:
2.350		HIGH:
2.395		ASK:
0.000		VOLUME:
3.98M
CHG(%):
1.70		PREV:
2.350		LOW:
2.240		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Feb 262.3502.3952.2402.3103.98M
10 Feb 262.2802.4102.2602.3306.55M
09 Feb 262.2702.3602.1602.2605.8M
06 Feb 262.4702.5002.2302.2607.93M
05 Feb 262.4402.5402.4002.4355.11M
04 Feb 262.6602.6602.3202.4606.85M
03 Feb 262.4802.7552.3822.6707.08M
02 Feb 262.3002.6302.2702.4808.76M
30 Jan 262.4302.4702.2702.2804.64M
29 Jan 262.5702.5702.4002.4204.83M

PROFILE

Name:Gossamer Bio Inc
About:Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:3115 Merryfield Row, San Diego, CA, United States, 92121
Website:https://www.gossamerbio.com
CUSIP:38341P102
CIK:0001728117
ISIN:US38341P1021
FIGI:BBG00MVWLLM2
LEI:549300ZOC0N2W6PSFR58

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-9.56 
Forward P/E:-4.11 
PEG Ratio:0.05 
Price to Sales:13.94 
Price to Book:-6.77 
Operating Margin:-3.37 
Return on Assets:-0.30 
Return on Equity:-7.83 
EPS Ratio:-0.69 
Revenue:40.24M 
Shares:231.46M 
Market Cap:534.66M 

TECHNICAL INDICATORS

MA5:2.320.4%
MA10:2.393.5%
MA20:2.518.6%
MA50:2.9126.1%
MA100:2.7719.8%
MA200:2.243.3%
STO9:9.09 
STO14:6.82 
RSI14:30.98 
WPR14:-89.77 
MTM14:-0.40
ROC14:-0.15 
ATR:0.23 
Week High:2.6615.2%
Week Low:2.166.9%
Month High:3.0029.8%
Month Low:2.163.3%
Year High:3.8767.5%
Year Low:0.76203.9%
Volatility:12.49